Surveillance of Salmonella enterica serovar  Typhi in Colombia, 2012-2015. by Diaz-Guevara, Paula et al.
RESEARCH ARTICLE
Surveillance of Salmonella enterica serovar
Typhi in Colombia, 2012–2015
Paula Diaz-GuevaraID1*, Lucy Angeline Montaño1, Carolina Duarte1, Gabriela Zabaleta1,
Mailis Maes2, Julio Cesar Martinez Angarita3, Duy Pham Thanh4, William Leo´n-Quevedo5,
Carlos Castañeda-Orjuela5, Claudia Jimena Alvarez Alvarez3, Jaime Guerrero3,
Miriam Moroni6, Josefina Campos6, Enrique Pe´rez7, Stephen BakerID2*
1 Grupo de Microbiologı´a, Instituto Nacional de Salud, Bogota´, Colombia, 2 Cambridge Institute of
Therapeutic Immunology & Infectious Disease (CITIID), The University of Cambridge, Cambridge, United
Kingdom, 3 Vigilancia y Ana´lisis de Riesgo en Salud Pu´blica, Instituto Nacional de Salud, Bogota´, Colombia,
4 Oxford University Clinical Research Unit, The Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam,
5 Observatorio Nacional de Salud, Instituto Nacional de Salud, Bogota´, Colombia, 6 Red Pulsenet Latino
Ame´rica y el Caribe, Subregional, Instituto Carlos Malbran, Buenos Aires, Argentina, 7 Health Emergencies
Department, Pan American Health Organization/World Health Organization, PAHO/WHO, Washington DC,
United States of America
* pdiaz@ins.gov.co (PDG); sgb47@medschl.cam.ac.uk (SB)
Abstract
Salmonella Typhi (S. Typhi) is the causative agent of typhoid fever; a systemic disease
affecting ~20 million people per year globally. There are little data regarding the contempo-
rary epidemiology of typhoid in Latin America. Consequently, we aimed to describe some
recent epidemiological aspects of typhoid in Colombia using cases reported to the National
Public Health Surveillance System (Sivigila) between 2012 and 2015. Over the four-year
reporting period there were 836 culture confirmed cases of typhoid in Colombia, with the
majority (676/836; 80.1%) of reported cases originated from only seven departments. We
further characterized 402 S. Typhi isolates with available corresponding data recovered
from various departments of Colombia through antimicrobial susceptibility testing and
molecular subtyping. The majority (235/402; 58.5%) of these typhoid cases occurred in
males and were most commonly reported in those aged between 10 and 29 years (218/402;
54.2%); there were three (0.74%) reported fatalities. The overwhelming preponderance
(339/402; 84.3%) of S. Typhi were susceptible to all tested antimicrobials. The most com-
mon antimicrobial to which the organisms exhibited non-susceptibility was ampicillin (30/
402;7.5%), followed by nalidixic acid (23/402, 5.7%). Molecular subtyping identified sub-
stantial genetic diversity, which was well distributed across the country. Despite the diffuse
pattern of S. Typhi genotypes, we identified various geographical hotspots of disease asso-
ciated with local dominant genotypes. Notably, we found limited overlap of Colombian geno-
types with organisms reported in other Latin American countries. Our work highlights a
substantial burden of typhoid in Colombia, characterized by sustained transmission in some
regions and limited epidemics in other departments. The disease is widely distributed across
the country and associated with multiple antimicrobial susceptible genotypes that appear to
be restricted to Colombia. This study provides a current perspective for typhoid in Latin
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America and highlights the importance of pathogen-specific surveillance to add insight into
the limited epidemiology of typhoid in this region.
Author summary
Typhoid fever is a systemic infectious disease of humans caused by the bacterium Salmonella
Typhi. Typhoid fever is transmitted by contaminated food and water and is considered
endemic in many low- and middle-income countries (LMICs) in Africa and Asia. In contrast,
typhoid fever is less commonly reported in Latin America; therefore, we aimed to contribute
to the knowledge of Typhoid fever in Colombia. Our data suggests a substantial burden of
typhoid in Colombia, which is characterized by continual transmission in some regions and
temporary epidemics in other locations. The disease is widely distributed throughout Colom-
bia and associated with multiple genotypes that are largely susceptible to the majority of antibi-
otics used to treat the infection. It appears that the current epidemiology of typhoid in
Colombia is distinct from Africa and Asia and largely restricted to organisms that are circulat-
ing nationally rather than internationally. This study provides a recent perspective for typhoid
in Latin America and highlights the importance of pathogen-specific surveillance to add
insight into the epidemiology of typhoid in this region.
Introduction
Salmonella enterica serovar Typhi (S. Typhi) is the causative agent of typhoid fever, a systemic
disease that occurs only in humans [1]. S. Typhi is transmitted through contaminated food
and water or via contact with fecal material from acute or chronically infected individuals
[1,2]. The annual global burden of typhoid is estimated to be 20.6 million cases with 223,000
deaths [3]. Typhoid is endemic in parts of South Asia, sub-Saharan Africa, Southeast Asia, and
also Latin America [4]. Outbreaks and sporadic cases are common in many low- and middle-
income countries (LMICs) within these regions, particularly in locations where sanitary condi-
tions are poor [5].
Antimicrobial resistance (AMR) has become a major global issue in typhoid. The evolution
and international spread of AMR in S. Typhi in Asia and Africa has been mainly driven by a
clonal expansion of a specific haplotype (H58/genotype 4.3.1) [6,7]. These organisms are fre-
quently multi-drug resistant (MDR) (resistant to ampicillin, chloramphenicol, and co-trimox-
azole), and often exhibit reduced susceptibility to fluoroquinolones [8]. More recently, an
extensively drug-resistance (XDR) S. Typhi clone carrying a plasmid encoding resistance to
fluoroquinolones and third generation cephalosporins has been reported in Pakistan [9].
Typhoid is largely accepted to be endemic in parts of Latin America; it is estimated that the
region has a medium incidence of typhoid fever (53/100,000 people) corresponding with
>273,000 cases annually [4,5]. However, despite this estimation, the burden of disease in spe-
cific Latin American countries, the epidemiology, and the population structure of the circulat-
ing organisms are ill defined. Within the region, Colombia is considered to have a particularly
low burden of typhoid fever [10], but much of the available data regarding typhoid fever in
Colombia are historic and contemporary data are limited. In 2003 Colombia reactivated a
national typhoid surveillance program and the notification of typhoid cases to the National
Surveillance System Public Health (Sivigila) became mandatory in 2006 [11]. According to the
official reporting system, the national incidence of typhoid (and paratyphoid) fever in Colom-
bia remained relatively stable between 2008 and 2012 with a mean of 0.16 cases per 100,000
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inhabitants annually [12]. In 2013, the incidence of the disease increased to 1.95 per 100,000
inhabitants and then declined to 0.16, 0.38, and 0.48 cases per 100,000 inhabitants in 2014,
2015, and 2016, respectively [13]. Routine surveillance data revealed a fluctuating trend of
typhoid fever between differing departments in Colombia and raised concerns about the emer-
gence and spread of AMR S. Typhi.
With the aim of assessing the geographical distribution and disease trends of typhoid fever
in Colombia, we examined a collection of S. Typhi isolates with corresponding metadata accu-
mulated by the national surveillance system between 2012 and 2015. Our specific objectives
were to provide a more detailed insight into the distribution of typhoid fever in Colombia by
characterizing S. Typhi organisms isolated from various Colombian departments with differ-
ing disease incidences via genotyping, antimicrobial susceptibility profiling, and assessing the
geographical distribution of the cases.
Methods
Ethics statement
The study was conducted according to the principles expressed in the Declaration of Helsinki.
Based on the policy of Instituto Nacional de Salud, Colombia, this study involved analysis of
routinely collected surveillance data and thus did not require ethical review. The collection
and use of clinical information or human biological specimens were conducted with prior oral
informed consent from patients with suspected typhoid fever. Patients were offered diagnostic
testing through the routine culture of stool and blood specimens as part of standard clinical
care. Patient data was reviewed and analyzed anonymously.
Study design
This was a retrospective study using data from the using available data from various depart-
ments of Colombia from cases reported to the National Surveillance System Public Health
(Sivigila) between 2012 and 2015 with the code for typhoid and paratyphoid fever (INS320).
The 836 typhoid cases were defined as those with a laboratory confirmed positive blood, stool,
sterile fluids, or bone marrow culture for Salmonella Typhi [14]. These data were associated
with a department of Colombia and a known population size to calculate the annual minimum
incidence of disease using data from DANE 2019 (https://www.dane.gov.co/index.php/
estadisticas-por-tema/demografia-y-poblacion/series-de-poblacionand) and INS cases report
data (http://www.ins.gov.co/buscador-eventos/Paginas/Info-Evento.aspx.) (S1 Table). Due to
limited data in national disease reporting systems, only a subset (402) of isolates had additional
data and were available for microbiological characterization and genotyping, this subset of
data is shown in S2 Table. Microbiological data were combined with anonymized social and
demographic data, including sex, age, ethnic group, geographic location, and type of health
coverage according to the General Social Security Health System (GSSSH). Areas with lower
living standard and with sustained reporting of typhoid fever over time were considered to be
endemic for this disease; other areas with incidences lower than the national average were con-
sidered to be sporadic for this disease.
Bacterial identification and antimicrobial susceptibility testing
All isolates were identified and characterized phenotypically using standard biochemical test-
ing (Triple Sugar Iron Agar (TSI), Citrate, Urea, and motility), and the API20E biochemical
test kit (Biomerieux, USA). The Kauffmann-White-Le Minor serological scheme using specific
commercial antisera was used to identify organisms suspected to be S. Typhi (Difco, United
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States) [15]. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disk dif-
fusion method against amoxicillin-clavulanic acid (AMC), chloramphenicol (CHL), nalidixic
acid (NAL), and tetracycline (TET). Minimum Inhibitory Concentrations (MIC) were deter-
mined using the MicroScan autoSCAN-4-System (Beckman Coulter) against ampicillin
(AMP), cefotaxime (CTX), ceftriaxone (CRO), ceftazidime (CAZ), ciprofloxacin (CIP), and
trimethoprim-sulfamethoxazole (SXT), according to the CLSI standards [16]. MDR was
defined as resistance to ampicillin, chloramphenicol, and co-trimoxazole. We additionally
aimed to identify potential Extended-Spectrum Beta-Lactamase (ESBLs) activity mediated by
the blaSHV, blaTEM, and blaCTX-M genes by PCR amplification as previously described [17].
Molecular subtyping
All 402 available organisms were subtyped following standardized PulseNet protocols using
Pulsed Field Gel Electrophoresis (PFGE) [18]. Genomic DNA was restriction digested with
XbaI enzyme (Promega, USA) and Salmonella Braenderup H9812 used as the reference stan-
dard. Digested genomic profiles were analyzed with Gelcompare 4.0 software (Applied Maths,
Belgium) applying the Dice coefficient and UPGMA method; tolerance and optimization were
set at 1.5% [19]. All PFGE data were uploaded to the Regional Database of the PulseNet Latin
America and Caribbean Network (PNLA&C) hosted by the PAHO/WHO. All PFGE pattern
codes were assigned following the PulseNet International guidelines for nomenclature, which
includes two letters for the country or region, three letters for the serovar, three characters for
the enzyme and four digits for the profile number (e.g. ALJPPX01.0001)[20].
Data analysis
ArcGIS 9.3 software (ESRI, Redlands, CA, USA) was used for geographical localization of the
various PFGE patterns. The scale of the base cartography information for the entire country or
individual departments was 1:25,000. Geospatial clustering was assessed using a Kernel density
estimation (KDE), with the estimation was applied to whole data set using quartic kernel func-
tion with a bandwidth in a scale of outputs and 1Km for Cucuta city, with an analysis of 5Km
drawing a circle with radius (r) around each point pattern and dividing point number inside
the circle by its area [21]. This approach permitted us to identify hotspots for typhoid, which
was defined case clustering within the defined spatial distribution [22]. All maps were con-
structed using R software version 3.4.4. Data were compiled, tabulated, and ordered using
Microsoft Excel and all statistical analyses was performed in R statistical software 3.4.4. PFGE
analyses were performed to identify the most representative cluster XbaI-PFGE (III) grouping
and to compare the distribution of the most frequent PFGE patterns (COINXXJPPX01.0115
and COINXXJPPX01.0008 against the minor PFGE patterns) with respect to the selected vari-
able: origin of the isolate, sex of the patient, year of isolation, and antimicrobial susceptibility
profile. Chi-squared test and Fisher’s test was used to test the association between PFGE cluster
and antimicrobial susceptibility profile. A 95% confidence interval (95CI) was calculated for
all statistical variables; a p value of<0.05 was considered statistically significant.
Results
The epidemiology of typhoid fever in Colombia
Typhoid fever is a reportable disease in Colombia, and we reviewed all available data regarding
typhoid in the regional Colombian reporting systems inclusively between 2012 and 2015. Over
the four-year reporting period there were 836 culture confirmed cases of typhoid (S1 Table).
The cases were widely distributed through the country and 27 of the 32 departments reported
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the disease (Fig 1). The majority (676/836; 80.1%) of reported cases originated from only seven
departments; Antioquia (n = 233), Norte de Santander (n = 233), Huila (n = 57), Meta
(n = 44), Choco´ (n = 41), Bolivar (n = 35), and Valle del Cauca (n = 33) (Fig 1). Using these
data, we were able to calculate a mean minimum incidence of disease, which ranged from
0.02/100,000 persons per year in Tolima to 4.34/100,000 persons per year in Norte de Santan-
der, which is in the Northeast of the country and located on the border with Venezuela (Fig 1).
The combined mean minimum incidence of disease over the four-year period of surveillance
was 0.44/100,000 persons per year (S1 Table).
Additional data and a paired organism were available for 402/836 (48.1%) cases in the
national database (S2 Table). The preponderance (235/402; 58.5%) of these typhoid cases
occurred in males and almost half of cases were affiliated to the national contributory health
insurance scheme (195/402; 48.5%). Typhoid fever was most commonly reported in those
Fig 1. The location of 402 cases of typhoid fever in Colombia (2012–2015). Map of Colombia with a 1:25,000 scale
base cartography and a Kernel function bandwidth outputs scale of 480 Km. Colored dots represents the residential
location and number of typhoid fever cases throughout the country by PFGE genotype (COINJPPX01-) (see key). The
seven departments with the greatest number of cases are labelled and the departments are color coded according to
their mean minimum incidence per 100,000 people over the study period (S1 Table, see key). Political division map
constructed in ArcGIS 9.3 software (ESRI, Redlands, CA, USA) from polygon shapefile accessed from https://www.
diva-gis.org/.
https://doi.org/10.1371/journal.pntd.0008040.g001
PLOS NEGLECTED TROPICAL DISEASES Typhoid fever in Colombia
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008040 March 10, 2020 5 / 17
aged�15 years (274/402; 68.15%) and was less frequently reported in children aged 0–4 (29/
402, 7.2%) and 6–14 years (99/402, 24.6%). The organisms originated from blood (364/402;
90.5%), stool (30/402; 7.5%), sterile body fluids (2/402; 0.5%), and bone marrow (2/402; 0.5%).
Approximately 90% (353/402) of these typhoid cases were hospitalized and three (0.74%) cases
died (Table 1). The majority (287/402; 71.4%) of these typhoid cases originated from the
municipal center of the respective departments. More specifically, the S. Typhi isolates were
recovered from both sporadic cases (299) and notified outbreaks (103) in 15 different depart-
ments. Four of these departments (Norte de Santander (n = 172), Antioquia (n = 115), Meta
(n = 25), and Huila (n = 22)) were considered to be typhoid endemic by Sivigila (Fig 1). The
remaining 68 available organisms were isolated in 11 departments where typhoid was consid-
ered sporadic.
Antimicrobial susceptibility
The overwhelming majority (339/402; 84%) of the screened S. Typhi organisms were suscepti-
ble to all tested antimicrobials. The remaining 63/402 (16%) isolates were non-susceptible
(intermediate or resistant) to either one (n = 45), two (15), or more (n = 3) of the tested
Table 1. The demographic features of typhoid fever in Colombia, 2012–2015.
Variable Category 2012 2013 2014 2015 Total
Cases (%) Cases (%) Cases (%) Cases (%) Cases (%)
Sex Female 21 (31.8) 34 (39.1) 42 (41.6) 70 (47.3) 167 (41.5)
Male 45 (68.2) 53 (60.9) 59 (58.4) 78 (52.7) 235 (58.5)
Health coverage a Contributory 33 (50.0) 55 (63.2) 38 (37.6) 69 (46.6) 195 (48.5)
Special 4 (6.1) 0 (0.0) 2 (2.0) 7 (4.7) 13 (3.2)
No affiliation 8 (12.1) 9 (10.3) 10 (9.9) 8 (5.4) 35 (8.7)
Exception 3 (4.5) 2 (2.3) 2 (2.0) 6 (4.1) 13 (3.2)
Subsidized 18 (27.3) 21 (24.1) 49 (48.5) 58 (39.2) 146 (36.3)
Ethnic background Raizal 0 (0) 0 (0.0) 1 (1.0) 0 (0.0) 1 (0.2)
Afro-Colombian 0 (0) 5 (5.7) 5 (5.0) 16 (10.8) 26 (6.5)
Others 66 (100) 82 (94.3) 95 (94.1) 132 (89.2) 375 (93.3)
Age groups <1 year 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.7) 1 (0.2)
1 to 9 years 8 (12.1) 8 (9.2) 24 (23.8) 22 (14.9) 62 (15.4)
10 to 1 9 years 12 (18.2) 22 (25.3) 27 (26.7) 40 (27.0) 101 (25.1)
20 to 29 years 24 (36.4) 32 (36.8) 20 (19.8) 41(27.7) 117 (29.1)
30 to 39 years 12 (18.2) 14 (16.1) 15 (14.9) 26 (17.6) 67 (16.7)
40 to 49 years 6 (9.1) 8 (9.2) 10 (9.9) 6 (4.1) 30 (7.5)
>50 years 4 (6.1) 3 (3.4) 5 (5.0) 12 (8.1) 24 (6.0)
Area b Municipal center 51 (77.3) 72 (82.8) 47 (46.5) 117 (79.1) 287 (71.4)
Populated Center 5 (7.6) 7 (8.0) 14 (13.9) 10 (6.8) 36 (9.0)
a) Health coverage corresponds to the various healthcare schemes. Contributive: health system through which all persons linked through an employment contract,
public servants, pensioners, retirees and independent workers with payment capacity make a monthly contribution to the health system. Special: social security regimes
of members of the national police, military forces, navy, and air force. Exception: social security system for members of the national social benefits funds for teachers,
public servants of Ecopetrol as well as servants of public universities. Subsidized: a mechanism through which the poorest population, without payment capacity, has
access to health services through a subsidy offered by the state.
b) Municipal center: the geographical area defined by an urban perimeter; whose limits are established by agreements of the Municipal Council. It corresponds to the
place where the administrative headquarters of a municipality is located. Populated center: A concentration of at last twenty contiguous, neighboring or semidetached
houses, located in the rural area of a municipality or a Department Corregimiento.
https://doi.org/10.1371/journal.pntd.0008040.t001
PLOS NEGLECTED TROPICAL DISEASES Typhoid fever in Colombia
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008040 March 10, 2020 6 / 17
antimicrobials. The most common antimicrobial to which the organisms exhibited non-sus-
ceptibility was ampicillin (28/402; 6.9%), followed by nalidixic acid (23/402; 5.7%). Non-sus-
ceptibility against fluoroquinolones (ciprofloxacin) was uncommon (9/402; 2.2%) (Table 2).
Resistance against ampicillin was more prevalent in Norte de Santander and Antioquia and
the four organisms found to be MDR were isolated throughout the study period in four differ-
ent regions (Bogota´, Antioquia, Norte de Santander, and Risaralda). Three organisms were
found to be blaTEM-1 positive by PCR amplification, but none were confirmed to be resistant
to third generation cephalosporins.
Genotyping of Colombian Salmonella Typhi
We pulsotyped the 402 available S. Typhi isolates by XbaI-PFGE; 113 different restriction pat-
terns were identified (Fig 2). The estimated genetic variability in this collection of Colombian
S. Typhi was 28.1% and the genetic similarity was 49.7%. Of the 113 individual PFGE patterns
identified, nine were widely distributed throughout the country and shared between up to six
departments. The most commonly identified restriction patterns were COINJPPXO1.0115
(n = 114), COINJPPXO1.0008 (n = 61), COINJPPXO1.0083 (n = 21) (Table 3). These three
patterns represented approximately half (196/402; 48.6%) of the pulsotyped isolates and were
widely distributed across the country (Fig 2 and Table 3). We investigated potential epidemio-
logical/microbiological associations with the two most common restriction patterns
(COINJPPX01.0115 and COINJPPX01.0008) but found no significant association for either
pulsotype with patient age, location, sex, antimicrobial susceptibility profile, or year of isola-
tion (S2 Table).
A clustering analysis of the XbaI-PFGE digestions (cutoff >75% identity) distinguished
four clonal pulsotype groups that we designated group I-IV. Group I (13/402; 3.2%) consisted
of 13 isolates separated into two subgroups (Ia and Ib) and were isolated in seven departments
(Antioquia, Bogota´, Cesar, Huila, Meta, Norte de Santander, and Santander). Group II (27/
402; 6.7%) was comprised of 27 isolates in 2 sub-groups (IIa and IIb); these organisms were
again widely distributed between departments (Antioquia, Huila, Norte de Santander, Risar-
alda, Santander, and Valle). Group III was the prevailing (356/402; 88.5%) pulsotype group
with 82 different XbaI-PFGE patterns falling in four sub-groups (IIIa-IIId). These isolates
were identified in 14 departments (Antioquia, Atla´ntico, Bogota´, Bolivar, Boyaca´, Caldas,
Cauca, Cundinamarca, Huila, Meta, Nariño, Norte de Santander, Risaralda, and Valle) (Fig 2
and Table 3). Lastly, group IV was the smallest group (6/402; 1.5%) and were isolated in four
different departments (Antioquia, Norte de Santander, Santander, and Valle), each had a dif-
ferent restriction pattern (Table 4).
Table 2. The antimicrobial susceptibilities of Colombian S. Typhi, 2012–2015.
Antimicrobial Non-susceptible; N (%) �
Ampicillin 30 (7.5)
Amoxicillin-clavulanic acid 3 (0.7)
Chloramphenicol 3 (0.7)
Ciprofloxacin 9 (2.2)
Nalidixic acid 33 (5.7)
Trimethoprim/sulfamethoxazole 7 (1.7)
Tetracycline 12 (3.0)
� 402 S. Typhi isolates tested
https://doi.org/10.1371/journal.pntd.0008040.t002
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Fig 2. The distribution of major PFGE types Colombia (2012–2015). A) A PFGE-XbaI dendrogram of S. Typhi isolates in Colombia 2012–1015 indicating
clusters I-IV (color coded); key genotypes are indicated (genetic similarity 49.7%) B) The geographical distribution of major S. Typhi PFGE types by Colombian
department. Top left (purple); the seven departments in which cluster I (3 PFGE patterns) isolates were identified. Top right (yellow); the six departments in which
cluster II (21 PFGE patterns) isolates were identified. Bottom right (green); the fourteen departments in which cluster III (82 PFGE patterns) isolates were
identified. Bottom left (orange); the four departments in which cluster IV (6 PFGE patterns) isolates were identified. Political division maps constructed in R
studio (VERSION) from polygon shapefiles accessed from DIVA-gis (https://www.diva-gis.org/gdata).
https://doi.org/10.1371/journal.pntd.0008040.g002
Table 3. Salmonella Typhi PFGE-XbaI patterns shared between Colombian departments.
Location N (%) PFGE-Pattern; COINJPPX01- (cluster grouping)
0008 (III) 0012 (III) 0023 (III) 0032 (III) 0058 (III) 0115 (III) 0155 (III) 0156 (III) 0183 (I)
Antioquia 115 (28.6) 49 13 - - - 3 - - 5
Atla´ntico 4 (1) - - - 1 - - - - -
Bogota´ 20 (5) - - 1 2 2 4 1 1 1
Bolivar 6 (1.5) 1 - - - - 1 - 1 -
Boyaca´ 1 (0.3) - - - - - - - - -
Cundinamarca 2 (0.5) - - - - 1 - - - -
Cauca 1 (0.3) - - - - - - - - -
Cesar 1 (0.3) - - - - - - - - 1
Huila 22 (5.5) 1 - 2 - - - 5 1 1
Norte de Santander 172 (42.3) 1 - - - - 103 - - 2
Nariño 11 (2.7) 8 1 - - - - - - -
Meta 25 (6.2) - - - 12 4 - - - -
Risaralda 3 (0.7) 1 - - - - - - - -
Santander 7 (1.7) - - - - - 3 - - 1
Valle 12 (3.0) - - - - - - - - -
Total 402 61 14 3 15 7 114 6 3 11
https://doi.org/10.1371/journal.pntd.0008040.t003
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The spatial distribution of Salmonella Typhi pulsotypes in Colombia
We further investigated the spatial distribution of the most common pulsotypes and also
pulsotypes associated with outbreaks. We performed a kernel spatial analysis, mapping the most
frequently identified PFGE patterns in higher incidence areas. Pulsotype COINXXJPPX01.0115
in Group III was found in five departments but was most commonly identified in Cucuta´ city
Table 4. The distribution of S. Typhi by antimicrobial susceptibility profile and relationship with PFGE cluster by Colombian department.
Antimicrobial susceptibility profile N Cluster PFGE-XbaI Pattern COINJPPX01- Departments (Year)
AMP(R) 2 I 0183 Antioquia (2015)
5 III 0008(2)-0012-0019-0085 Antioquia (2015)
1 III 0058 Bogota´ (2015)
1 III 0032 Meta (2015)
9 III 0005-0083(2)-0115(3) -0124-0171-0186 Norte de Santander (2015)
AMP(I) 1 IV 0110 Norte de Santander (2015)
1 III 0008 Antioquia (2015)
3 III 0083-0115(2) Norte de Santander (2013–2015)
AMP(I)-CIP(I) 1 III 0008 Nariño (2015)
AMP(R)-SXT(R) 3 III 0090,0096 Antioquia (2015)
NAL(I)-AMP(R) 1 III 0008 Nariño (2015)
NAL(I)-CIP(I) 1 II 0135 Norte de Santander (2012)
1 III 0074 Norte de Santander (2012)
3 III 0008(3) Nariño (2015)
NAL(R) 1 III 0032 Meta (2015)
2 III 0019–0230 Antioquia (2012–2015)
1 III 0127 Bolı´var (2013)
4 III 0006(3), 0106 Huila (2013–2015)
1 IV 0221 Antioquia (2012)
NAL(I) 2 III 0074,0083 Norte de Santander (2012–2015)
1 IV 0075 Norte de Santander (2012)
NAL(R)-CIP(I) 1 III 0032 Meta (2015)
1 III 0187 Norte de Santander (2014)
NAL(R)-CIP(I) 1 III 0120 Valle (2015)
SXT(R) 1 III 0008 Antioquia (2012)
1 III 0115 Norte de Santander (2015)
1 III 0032 Meta (2015)
TET(R) 1 II 0224 Norte de Santander (2014)
2 III 0008(2) Antioquia (2014)
1 III 0156 Bogota´ (2015)
3 III 0115(2)-0214 Norte de Santander (2012,2013)
TET(R)-AMC(I) 1 III 0218 Norte de Santander (2014)
TET(R)-CHL(R) 1 III 0115 Norte de Santander (2015)
TET(R)-CHL(R)-AMC(R) 1 III 0199 Bogota´ (2012)
TET(R)-CHL(R)-NAL(I)-CIP(I) 1 II 0193 Risaralda (2015)
TET(R)-NAL(I)-AMC(I)-SXT(R)-AMP(R) 1 I 0183 Antioquia (2014)
Total 63
Antimicrobials: AMC; amoxicillin-clavulanic acid, AMP; ampicillin, CHL; chloramphenicol, CTX; cefotaxime, CAZ; ceftazidime, CIP; ciprofloxacin, NAL; nalidixic
acid, STX; trimethoprim/Sulfamethoxazole, TET; tetracycline.
https://doi.org/10.1371/journal.pntd.0008040.t004
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(Norte de Santander department); and clustered in the localities of Cucuta´ (n = 75) (X 2 38.9944;
p<0.0001), Villa del Rosario (n = 7) (X 2 12.9331; p<0.0001), and Los Patios (n = 10) (X 2
2.5302; p 0.11168435). This analysis also suggested a high density of cases in the neighborhoods of
Aeropuerto, Libertad, San Andresito, and Carlos Ramirez in the south and west of Cucuta´
city (Fig 3). Pulsotype COINXXJPPX01.0008 was also in Group III and identified in six depart-
ments but clustered in Loma Verde village, in Apartado´ (Antioquia department) (n = 39) (X 2
10.4580; p<0.0001) (Fig 4). The next most common pulsotypes were COINXXJPPX01.0083,
COINXXJPPX01.0032, and COINXXJPPX01.0155; these pulsotypes clustered in Norte de Santan-
der department (n = 21) (X 2 116.4260; p<0.0001), Meta department (n = 12) (X 2 43.1324;
p<0.0001), and Huila department (n = 5) (X 2 16.4014; p<0.0001); respectively (Fig 4).
Pulsotypes associated with reported outbreaks (103 isolates) again typically belonged to
group III. Between January and April 2012, four typhoid cases were cultured confirmed in
Huila department and shared the same COINJPPXO1.0155 restriction pattern. The local water
supply was postulated to be the most probable source. Further, between March and June 2015,
15 confirmed S. Typhi cases were reported in Cucuta´ (Norte de Santander department). These
isolates displayed several PFGE patterns; however, 5/15 (33.3%) were identical (COIN-
JPPXO1.0083). The biggest outbreak was recorded between February 2014 and March 2015 in
the Antioquia department. Four villages (Loma Verde, Campo Alegre, Santo Domingo, and
Zungo) were affected and 75 confirmed cases of S. Typhi were reported with an unknown
source. Several different PFGE patterns were identified but COINJPPXO1.0008 (32/75; 42.6%)
was the dominant pulsotype.
Colombian Salmonella Typhi in a Latin American framework
To assess the genetic relatedness of Colombian S. Typhi with organisms circulating in Latin
America we selected 29 pulsotypes shared by at least two organisms and compared these with
Fig 3. Clustering of typhoid fever in Cucuta´ city. 15 km Kernel density plot map of Cucuta´ city in Norte de
Santander province bordering Venezuela showing the spatial clustering of typhoid fever cases. The darker blue shows a
higher intensity of cases. Red dots highlight the individual typhoid cases and their corresponding PFGE-XbaI digestion
patterns. Map manually constructed in ArcGIS 9.3 software (ESRI, Redlands, CA, USA).
https://doi.org/10.1371/journal.pntd.0008040.g003
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representative restriction patterns in the regional PNLA&C database, which at the time of this
study contained 967 isolates obtained from Argentina, Bolivia, Brazil, Chile, Colombia, Costa
Rica, Guatemala, Paraguay, Peru, Uruguay, and Venezuela. These 967 isolates displayed 329 dis-
tinct XbaI restriction patterns [23]. More generally, the Latin American S. Typhi isolates could
be broadly classified into eight regional digestion patterns (ALJPPX01.0016, ALJPPX01.0045,
ALJPPX01.0048, ALJPPX01.0050, ALJPPX01.0076, ALJPPX01.0089, ALJPPX01.0191, and
ALJPPX01.0195). Our analysis determined that six pulsotypes found in Colombia had also been
reported in Chile, Argentina, Venezuela, and Peru. However, the three most common Colom-
bian pulsotypes were not found among the pulsotypes reported by other Latin American coun-
tries (Fig 5).
Discussion
This study characterized S. Typhi isolated from cases of typhoid fever collected by the Sivigila
National Surveillance System and laboratory from across Colombia between 2012–2015. Our
work demonstrates that there is a substantial burden of typhoid fever in Colombia [22]. The
disease epidemiology in this Latin American country appears to be highly variable, with
typhoid associated with sustained transmission in some regions and short-term outbreaks in
other departments. We additionally found that typhoid is broadly distributed and caused by
multiple genotypes, of which the majority may be constrained to Colombia and do not appear
to circulate between other Latin American countries.
We identified a particularly high burden of typhoid in Cucuta´ city in Norte de Santander
department and in other more remote locations including Antioquia, Meta, and Huila,
Fig 4. The geographic distribution of typhoid fever in specific Colombian departments. Colored dots represent the residential location and number of typhoid
fever cases throughout the country by PFGE genotype (COINJPPX01-) (see key). A) Map of Antioquia department showing the location of typhoid cases by
municipality; Apartado´ (n = 69) and Turbo (n = 19). B) Map of Huila department showing the location of typhoid cases by municipality; Garzon (n = 15) and Agrado,
Gigante, Palermo, and Neiva (all n = 5). C) Map of Meta department showing the location of typhoid cases by municipality; Granada; (n = 19), and Villavicencio,
Mesetas, El Castillo, and Fuente de Oro (all n = 6). Political division maps constructed in ArcGIS 9.3 software (ESRI, Redlands, CA, USA) from polygon shapefiles
accessed from https://www.diva-gis.org/. Kernel function bandwidth with a scale of outputs of 80Km.
https://doi.org/10.1371/journal.pntd.0008040.g004
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indicating both urban and rural disease transmission. Similar observations have been made in
Sub-Saharan Africa [24]. Colombia has been classified as a country with an intermediate bur-
den of typhoid fever (1.2 to 2.0 cases per 100,000 people/year) [4,5,25]. However, it is known
that epidemics of typhoid fever can arise sporadically in Latin America [26]; therefore, we
suspect the underreporting of disease in the national data capturing system as the national sur-
veillance system is unlikely to capture the full extent of the disease burden in Colombia. Fur-
thermore, given the geographical landscape of Colombia, there is the potential for a lack of
typhoid reporting in many rural locations, leading to a shortfall in disease notification of these
cases to the central surveillance system. Our data were enriched for organisms arising from the
major cities in well-connected departments. This lack of an equal distribution of clinical labo-
ratories across the country is likely to induce substantial bias in any conclusion regarding the
distribution of typhoid in Colombia. Many rural locations do not have access to standardized
blood culturing systems or a resident clinical microbiologist to identify infecting organisms
[27]. The highest density of laboratories with the ability to perform blood culture can be found
Fig 5. Colombian Salmonella Typhi in a Latin American context. Dendrogram of PFGE-XbaI S. Typhi digestions in the context of regional PFGE patterns, from the
PNLA&C Database. The shared PFGE patterns between Chile ALJPPX01.0050, ALJPPX01.0045, Argentina and Chile ALJPPX01.0048, Venezuela ALJPPX01.0191,
ALJPPX01.0076, Peru ALJPPX01.0195, and Argentina ALJPPX01.0089 with those found circulating in Colombia (COINXXJPPX01- and INS-S-596) are highlighted on
the right of the diagram.
https://doi.org/10.1371/journal.pntd.0008040.g005
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in Nariño, Boyaca´, Atla´ntico, Bolı´var, Valle del Cauca, Santander, Antioquia, and Bogota´.
Whereas, the lowest density of clinical laboratories with the ability to perform blood culture is
in the departments of Vaupes, San Andres and Providence, Guainı´a, Quindı´o, Vichada, Gua-
viare, Amazonas, and Putumayo. Furthermore, almost half the cases were isolated as part of
the national contributory health insurance scheme, suggesting bias towards those that can
afford to pay for improved healthcare services. The lack of a surveillance system that encom-
passes the entire country, the use of non-standardized protocols, and an inconsistent health
insurance system may also limit case numbers being detected and reported [28].
We observed that the majority S. Typhi isolates from this study were pan-susceptible to the
tested antimicrobials, with MDR and fluoroquinolone resistance phenotypes being uncom-
mon. Consequently, our data suggest that traditional first-line antimicrobials and the fluoro-
quinolones are likely to remain largely effective for the treatment of typhoid fever in Colombia
[29]. Local treatment guidelines for typhoid do not yet exist in Colombia and use standard of
care empirical treatment for a patient suspected to have typhoid fever, which is typically a
third-generation cephalosporin, such as ceftriaxone. However, many hospitals follow the
guidelines of the WHO and then switch to a fluoroquinolone when S. Typhi has been isolated
from blood [30]. We identified no ESBL producing S. Typhi; other ESBL producing Salmonella
have been reported from Latin America, but unlike the epidemiology of S. Typhi outside of the
region, drug resistance appears not to be an issue [31,32]. This observation is probably associ-
ated with a lack of H58 (genotype 4.3.1) S. Typhi outside of Asia and Africa. The integration of
whole genome sequencing (WGS) with conventional epidemiology has been shown to be
highly valuable in the detection of outbreaks, strengthening AMR surveillance, and public
health investigations [33]. Our future direction aims to introduce WGS in our current surveil-
lance network to monitor for the emergence of H58 S. Typhi in Latin America and continue to
track the local spread of other AMR genotypes.
This study identified specific geographical regions that may be hot spots of S. Typhi in
Colombia. For instance, Cucuta´ in Norte de Santander department and two localized clusters
across Antioquia (spanning Apartado´, Carepa, Chigorodo, Itsmina, Medellin, Murindo, Rio-
sucio, Turbo, and Vigia del Fuerte) exhibited extensive case clustering of specific genotypes.
These locations have a propensity for poor sanitation and are the hubs for recent massive dis-
placement of provincial workers in a low sociodemographic population of indigenous people
and immigrants [34]. The more recent typhoid epidemiology in Colombia (and other Latin
American countries) may be highly volatile as a consequence of the Venezuelan migratory sit-
uation. Indeed, this highest minimum incidence was identified in Norte de Santander, which
lies on the border with Venezuela. However, due to the limitations of data collection and a
porous border we were only able to identify two patients that were confirmed to have entered
Colombia from the state of Ta´chira, Venezuela. This crisis has induced a convergence of social
and public health problems and should be the targeted for the provision of appropriate public
health interventions and future research initiatives [35].
Previous studies have suggested that multiple S. Typhi PFGE patterns circulate at a regional
level across Latin America [36,37]. A regional comparison between typhoid outbreaks in
Argentina and Colombia found that many isolates shared highly similar restriction patterns
[38]. In this study, two restriction patterns dominated, which included 36.6% of the isolates
from outbreaks in the departments of Putumayo and Antioquia. More recently, we compared
S. Typhi isolates from 2005–2008 from Argentina, Brazil, Colombia, and Chile and found that
various PFGE patterns were exchanged between Colombia and Brazil [36]. Latterly, we com-
pared S. Typhi isolates from Colombia with the PNLA&C database to identify shared PFGE
patterns; two common Colombian restriction patterns were indistinguishable with organisms
found in Argentina and Chile and were hypothesized to be associated with sustained regional
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circulation [37]. A study comparing organisms isolated between 1996 and 2016 in ten coun-
tries across the continent described 278 regional XbaI-PFGE patterns, of which 34 were shared
between several countries [23]. In this broad Latin American study, Colombia possessed 23
XbaI-PFGE patterns that were identical to organisms isolated in Argentina, Brazil, Chile, Gua-
temala, Peru, and Venezuela. These studies suggest a high level of genetic diversity of S. Typhi
circulating within individual countries in Latin America of which some variants have the abil-
ity to spread successfully across the region. Again, the adoption of WGS should facilitate a
deeper understanding of the population structure and dynamics of S. Typhi in this region.
This study has limitations; due to the nature of the surveillance system(s). The data may be
incomplete as cases are detected passively and particular departments may have a lack of facili-
ties for diagnosing typhoid. Additionally, the population at risk and health seeking behavior
were not assessed in our study making an accurate incidence estimation unfeasible. Further-
more, bacterial genotyping was limited to PGFE, which is no longer the gold standard method
for genotyping S. Typhi. However, due the limitation of the capacity to perform WGS across
Latin America, PFGE remains the currently preferred subtyping method by PNLA&C [39].
Despite these limitations, this study highlights that there is a significant burden of typhoid in
Colombia and the political instability in Venezuela may place additional pressures on typhoid
control in Latin America.
Our study provides a current perspective of typhoid fever in a Latin America country and
highlights the importance of pathogen-specific surveillance to add insight into the epidemiol-
ogy of typhoid in this region. Sustained surveillance and the adoption of WGS in high risk
areas should aid in disease control, our ability to identify new AMR variants, and permit us fol-
low specific clones and lineages in Colombia and across Latin America.
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